News

A pioneering digital platform, dedicated to trauma prevention and management for frontline professionals, has secured funding of £1.2m from investors.

Investment comes after surging demand for Rhizocore’s fungal tree health pellets.

1nhaler, a Scotland-based drug delivery device developer, has secured an additional £1.5 million in seed funding to drive development of its novel pop-up cardboard dry powder inhaler (DPI).

Scottish Brain Sciences (SBS), a leading clinical research organisation dedicated to transforming the early detection and treatment of Alzheimer’s disease and other neurodegenerative conditions, has opened a new state-of-the-art clinical research centre at ONE BioHub, Aberdeen.

SOLASTA® Bio, specialising in the next generation of green insecticides, has relocated to purpose-built facilities at the West of Scotland Science Park, marking a major milestone in the company's growth journey since 2021.

Scottish Enterprise is launching the next phase of its successful US MarketBooster programme, supporting innovative science and tech companies to enter and scale in the world’s largest market for technology products and services.

A Scottish company has been awarded funding to develop a tool for earlier diagnosis of canine osteoarthritis (OA) – a disease which affects up to 20% of dogs worldwide.

The Innovation Collaboration Framework, published by Innovate UK, in partnership with Scottish Enterprise, South of Scotland Enterprise and Highlands and Islands Enterprise, aims to help Scotland realise its bold vision to become one of the most innovative small nations in the world.

The James Hutton Institute has received a £3 million investment from Scottish Enterprise for its new high throughput phenotyping facility, part of the Advanced Plant Growth Centre (APGC), housed in its Crop Innovation Centre (CIC).

Danish materials technology company Y-MatTec A/S has announced the Port of Montrose as its preferred location for a DNV-certified grout production facility in the UK

Programme celebrates 2025 award winners as major funding boost and new partnership enhance support for academic entrepreneurs

A groundbreaking technology developed by Heriot-Watt University has received over £475,000 in funding to revolutionise how eczema is diagnosed and treated. The treatment could end years of trial-and-error treatment misery and long wait times for millions of patients across the UK.